Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) just unveiled an announcement.
4DMedical Limited has received confirmation from the U.S. Centers for Medicare & Medicaid Services (CMS) for reimbursement of its CT:VQ™ software, marking a significant step towards broad market adoption. This reimbursement, set at $650.50 per scan, allows hospitals and imaging centers to integrate the technology into their workflows without additional capital investment, enhancing accessibility and economic viability. The technology offers comprehensive lung function assessments without radioactive exposure, improving patient care and expanding diagnostic capabilities to facilities lacking nuclear medicine resources. With both FDA approval and Medicare reimbursement, 4DMedical is poised to accelerate commercial integration across the U.S., engaging with leading hospital groups and academic institutions.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company specializing in advanced imaging and artificial intelligence to revolutionize respiratory care. Their patented XV Technology® enhances standard scans to provide detailed functional insights, aiding in early detection and precise monitoring of lung diseases. The company’s software portfolio includes FDA-cleared solutions like XV Lung Ventilation Analysis Software and CT:VQ™, which set new standards in cardiothoracic imaging. These solutions are delivered through a Software-as-a-Service model, integrating seamlessly into existing hospital infrastructure to improve physician productivity and patient care.
Average Trading Volume: 2,037,403
Technical Sentiment Signal: Buy
Current Market Cap: A$265.4M
See more data about 4DX stock on TipRanks’ Stock Analysis page.